Abstract
NERVE growth factor (NGF) is a neurotrophic factor responsible for the differentiation and survival of sympathetic and sensory neurons as well as selective populations of cholinergic neurons1,2. NGF binds to specific cell-surface receptors but the mechanism for transduction of the neurotrophic signal is unknown. Several experiments using the NGF-responsive pheochromocytoma cell line, PC12, have implicated tyrosine phosphorylation in NGF-mediated responses, although no NGF-specific tyrosine kinases have been identified3. Here we show that NGF induces tyrosine phosphorylation and tyrosine kinase activity of the trk protooncogene product, a tyrosine kinase receptor whose expression is restricted in vivo to neurons of the sensory spinal and cranial ganglia of neural crest origin4. Tyrosine phosphorylation of trk by NGF is rapid, specific and occurs with picomolar quantities of factor, indicating that the response is mediated by physiological amounts of NGF. Activation of the trk tyrosine kinase receptor provides a possible mechanism for signal transduction by NGF.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Levi-Montalcini, R. Science 237, 1154–1161 (1987).
Gnahn, H., Heft, F., Heumann, R., Schwab, M. E. & Thoenen, H. Devl Brain Res. 9, 45–52 (1983).
Maher, P. A. Proc. natn. Acad. Sci. U.S.A. 85, 6788–6791 (1988).
Martin-Zanca, D., Barbacid, M. & Parada, L. F. Genes Dev. 4, 683–694 (1990).
Greene, L. A. & Tischler, A. S. Proc. natn. Acad. Sci. U.S.A. 73, 2424–2428 (1976).
Schubert, D., Heinemann, S. & Kidokoro, Y. Proc. natn. Acad. Sci. U.S.A. 74, 2579–2583 (1977).
Dichter, M. A., Tischler, A. S. & Greene, L. A. Nature 268, 501–504 (1977).
Alema, S., Casalbore, P., Agostini, E. & Tato, F. Nature 316, 557–559 (1985).
Klein, R., Martin-Zanca, D., Barbacid, M. & Parada, L. F. Development 4, 845–850 (1990).
Klein, R., Parada, L. F., Coulier, F. & Barbacid, M. EMBO J. 8, 3701–3709 (1989).
Martin-Zanca, D., Oskam, R., Mitra, G., Copeland, T. & Barbacid, M. Molec. cell. Biol. 9, 24–33 (1988).
Maher, P. A. J. Neurosci. Res. 24, 29–37 (1989).
Greenberg, M. E., Hermanowski, A. L. & Ziff, E. B. Molec. cell. Biol. 6, 1050–1057 (1986).
Greene, L. A. & Rein, G. Nature 268, 349–351 (1977).
Kim, U.-H. et al. J. biol. Chem. (in the press).
Thoenen, H. & Barde, Y. A. Physiol. Rev. 60, 1284–1335 (1980).
Morrison, D. K., Browning, P. J., White, M. F. & Roberts, T. M. Molec cell. Biol. 8, 176–185 (1988).
Kaplan, D. R., Morrison, D. K., Wong, G., McCormick, F. & Williams, L. T. Cell 61, 125–133 (1990).
Morrison, D. K. et al. Cell 58, 649–657 (1989).
Chao, M. V. in Handbook of Experimental Pharmacology Vol. 95/II (eds Sporn, M. B. & Roberts, A. B.) 135–165 (Springer-Verlag, 1990).
Sefton, B. M., Hunter, T., Ball, E. H. & Singer, S. J. Cell 24, 165–174 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaplan, D., Martin-Zanca, D. & Parada, L. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature 350, 158–160 (1991). https://doi.org/10.1038/350158a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/350158a0
This article is cited by
-
Neurochemical mechanism of muscular pain: Insight from the study on delayed onset muscle soreness
The Journal of Physiological Sciences (2024)
-
Analysis of β-nerve growth factor and its precursor during human pregnancy by immunoaffinity-liquid chromatography tandem mass spectrometry
Scientific Reports (2023)
-
ProNGF promotes brain metastasis through TrkA/EphA2 induced Src activation in triple negative breast cancer cells
Experimental Hematology & Oncology (2023)
-
Toward in vivo proof of binding of 18F-labeled inhibitor [18F]TRACK to peripheral tropomyosin receptor kinases
EJNMMI Research (2022)
-
Investigating the natural history and prognostic nature of NTRK gene fusions in solid tumors
Investigational New Drugs (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
